Second-generation antipsychotic drugs for anxiety disorders - Wikidata - wikimedia - TriplyDB

Second-generation antipsychotic drugs for anxiety disorders

Second-generation antipsychotic drugs for anxiety disorders

http://www.wikidata.org/entity/Q24240919

about

Reiki for depression and anxiety

P2860

Q24186631-30AB2003-D063-4B06-B945-671B654CD6C5

P2860

Second-generation antipsychotic drugs for anxiety disorders

http://www.wikidata.org/entity/Q24240919

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Second-generation antipsychotic drugs for anxiety disorders

@ast

Second-generation antipsychotic drugs for anxiety disorders

@en

Second-generation antipsychotic drugs for anxiety disorders

@en-gb

Second-generation antipsychotic drugs for anxiety disorders

@nl

type

label

Second-generation antipsychotic drugs for anxiety disorders

@ast

Second-generation antipsychotic drugs for anxiety disorders

@en

Second-generation antipsychotic drugs for anxiety disorders

@en-gb

Second-generation antipsychotic drugs for anxiety disorders

@nl

prefLabel

Second-generation antipsychotic drugs for anxiety disorders

@ast

Second-generation antipsychotic drugs for anxiety disorders

@en

Second-generation antipsychotic drugs for anxiety disorders

@en-gb

Second-generation antipsychotic drugs for anxiety disorders

@nl

P1433

Q24240919-7DE2420B-CCC7-4128-88F2-868F3438CE7C

P1476

Q24240919-02D6BFA2-C626-4C96-B163-724DB4B9AC3E

P2093

Q24240919-B55B95E6-86E4-491A-B9A2-6FD8EFFA34AF

P2860

Q24240919-1FF82746-EDD7-482D-A1C0-731C0EE83308

Q24240919-2374BF33-60C4-43B2-8D78-4FD932426D97

Q24240919-2661D785-BA2F-40AC-926F-112EC862FA2C

Q24240919-2BB6B67F-ABE6-4394-9B3B-B0A5137BD37E

Q24240919-5A0EFC21-33FF-4672-8C47-34DF8B5DC639

Q24240919-5F6F256A-DAF2-42C6-BD63-2E23837916FB

Q24240919-7A22DC2E-A9F5-4F8B-BC0C-41B05F42A97E

Q24240919-8744E86E-FD6D-4E17-AFB4-9A5C44D60520

Q24240919-88FB3D4D-308E-4CB5-AB46-DD5296795521

Q24240919-8A4707E2-DBFD-40A9-A565-8973A687022E

P31

Q24240919-B34C7239-7D0C-4A83-AF0C-BA14216C2B35

P356

Q24240919-E69E1F75-63AE-4559-A4E6-135499DE74DC

P50

Q24240919-4DC96CB8-DD76-4E6E-AFF4-BDFF70789B1B

Q24240919-8159C820-CBD6-4D6C-B027-6A1B14FB03AD

Q24240919-F5148F3D-251B-4DA6-B676-8D520A1D7113

P577

Q24240919-530E3E97-BE6E-44C3-96AC-AA25980C2245

P356

14651858.CD008120

P1433

Cochrane Database of Systematic Reviews

P1476

Second-generation antipsychotic drugs for anxiety disorders

@en

P2093

Anna M Depping

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

The assessment of anxiety states by rating

A new depression scale designed to be sensitive to change

Meta-analyses involving cross-over trials: methodological issues

Imputing missing standard deviations in meta-analyses can provide accurate results

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

Multicenter collaborative panic disorder severity scale.

P31

scholarly article

P356

10.1002/14651858.CD008120

http://www.w3.org/2001/XMLSchema#string

P50

Werner Kissling

P577

2009-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime